Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

CorPath GRX System

K-Number: K221464 · 2022-07-27

Decision Date2022-07-27
Product CodeDXX
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

CorPath GRX System is a medical device manufactured by Corindus, Inc.. It received FDA 510(k) clearance on 2022-07-27 under approval number K221464. The device is classified under product code DXX. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the CorPath GRX System?

CorPath GRX System is a medical device that received FDA 510(k) clearance on 2022-07-27. It is manufactured by Corindus, Inc.. The 510(k) number is K221464.

When was CorPath GRX System approved by the FDA?

CorPath GRX System received FDA 510(k) clearance on 2022-07-27, under approval number K221464.

What company makes CorPath GRX System?

CorPath GRX System is manufactured by Corindus, Inc..

What is the FDA product code for CorPath GRX System?

The FDA product code for CorPath GRX System is DXX.

Other Devices by Corindus, Inc.

View all 7 devices →

Related Devices (Code: DXX)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.